4,991
Views
4
CrossRef citations to date
0
Altmetric
Review

Principles of risk decision-making

, , , , , , , & show all

References

  • Abbas, W. T. 2021. Advantages and prospective challenges of nanotechnology applications in fish cultures: A comparative review. Environmental Science Pollution Research Institute 28 (7):7669–90. doi:10.1007/s11356-020-12166-0.
  • Acharya, K. P., T. R. Ghimire, and S. H. Subramanya. 2021. Access to and equitable distribution of COVID-19 vaccine in low-income countries. NPJ Vaccines 6:54–54. doi:10.1038/s41541-021-00323-6.
  • Adler, M. D. 2008. Risk equity: A new proposal. Harvard Environmental Law Review 32:1.
  • Agapova, M., E. B. Devine, B. W. Bresnahan, M. K. Higashi, and L. P. Garrison. 2014. Applying quantitative benefit–risk analysis to aid regulatory decision making in diagnostic imaging. Acad. Radiol. 21 (9):1138–43. doi:10.1016/j.acra.2014.05.006.
  • Alami, A., D. Krewski, D. Mattison, K. Wilson, C. A. Gravel, P. J. Villeneuve, P. J. Farrell, J. A. G. Crispo, and S. Perez-Lloret. 2022. Risk of myocarditis and pericarditis among young adults following mRNA COVID-19 vaccinations. Vaccines 10 (5):722. doi:10.3390/vaccines10050722.
  • Alberta Government. 2008. Alberta’s 2008 climate change strategy. Edmonton, AB: Government of Alberta. Accessed 3 August 2022. https://open.alberta.ca/publications/9780778567899.
  • Appleby, J. 2020. Will covid-19 vaccines be cost effective—and does it matter? Br Med J 371:m4491.
  • Arrieta, M. I., R. D. Foreman, E. D. Crook, and M. L. Icenogle. 2009. Providing continuity of care for chronic diseases in the aftermath of Katrina: From field experience to policy recommendations. Disaster Med Public Health Prep 3:174–82. doi:10.1097/DMP.0b013e3181b66ae4.
  • Austin, S. E., J. D. Ford, L. Berrang-Ford, M. Araos, S. Parker, and M. D. Fleury. 2015. Public health adaptation to climate change in Canadian jurisdictions. International Journal of Environmental Research and Public Health 12 (1):623–51. doi:10.3390/ijerph120100623.
  • Baan, R. A and K., Straif. 2022. The monographs programme of the international agency for research on cancer: A brief history of its preamble. ALTEX 39 443–50. doi:10.14573/altex.2004081.
  • Ball, P. 2020. The lightning-fast quest for COVID vaccines — And what it means for other diseases. Nature 589 (7840):16–18. doi:10.1038/d41586-020-03626-1.
  • Bao, C., D. Wu, J. Wan, J. Li, and J. Chen. 2017. Comparison of different methods to design risk matrices from the perspective of applicability. Procedia Comput Sci 122:455–62. doi:10.1016/j.procs.2017.11.393.
  • Benn, S., D. Dunphy, and A. Martin. 2009. Governance of environmental risk: New approaches to managing stakeholder involvement. Journal of Environmental Management 90 (4):1567–75. doi:10.1016/j.jenvman.2008.05.011.
  • Berthoud, B. 2014. The precautionary principle in EU risk regulation: A matter of priorities. Hamburg: Anchor Academic Publishing.
  • Bourque, L. B., J. M. Siegel, M. Kano, and M. M. Wood. 2007. Morbidity and mortality associated with disasters. In Handbook of disaster research, eds.Rodriguez, H., E.L. Quarantelli and R.R., Dynes , 97–112. New York: Springer.
  • Bowen, W. M., M. J. Salling, K. E. Haynes, and E. J. Cyran. 1995. Toward environmental justice: Spatial equity in Ohio and Cleveland. Annals of the Association of American Geographers 85 (4):641–63. doi:10.1111/j.1467-8306.1995.tb01818.x.
  • Braathen, N., H. Lindhjem, and S. Navrud 2009. Valuing lives saved from environmental, transport and health policies: A meta-analysis of stated preference studies. OECD: Paris. Available at www.oecd.org/env/policies/vsl. (Accessed July 22, 2022).
  • Bratu, A., K. G. Card, K. Closson, N. Aran, C. Marshall, S. Clayton, M. K. Gislason, H. Samji, G. Martin, M. Lem, et al. 2022. The 2021 Western North American heat dome increased climate change anxiety among British Columbians: Results from a natural experiment. Journal of Climate Change and Health 6:100116. doi:10.1016/j.joclim.2022.100116.
  • Burnett, R., H. Chen, M. Szyszkowicz, N. Fann, B. Hubbell, C. A. Pope 3rd, J. S. Apte, M. Brauer, A. Cohen, S. Weichenthal, et al. 2018. Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. Proc. Natl. Acad. Sci. U.S.A. 115 (38):9592–97.
  • Canada Energy Regulator. 2021. Provincial and territorial energy profiles - Quebec. Accessed 8 August 2022. https://www.cer-rec.gc.ca/en/data-analysis/energy-markets/provincial-territorial-energy-profiles/provincial-territorial-energy-profiles-canada.html.
  • Castorina, R., and T. J. Woodruff. 2003. Assessment of potential risk levels associated with U.S. Environmental protection agency reference values. Environ. Health Perspect. 111 (10):1318–25. doi:10.1289/ehp.6185.
  • Cazenave, J., A. Ale, C. Bacchetta, and A. S. Rossi. 2019. Nanoparticles toxicity in fish models. Current Pharmaceutical Design 25 (37):3927–42. doi:10.2174/1381612825666190912165413.
  • CEPA: Canadian Environmental Protection Act. Environment and Climate Change Canada (1999). https://laws-lois.justice.gc.ca/eng/acts/c-15.31/.
  • Chao, E., and D. Krewski. 2008a. A risk-based classification scheme for genetically modified foods I: Conceptual development. Regulatory Toxicology and Pharmacology 52 (3):208–22. doi:10.1016/j.yrtph.2008.08.006.
  • Chao, E., and D. Krewski. 2008b. A risk-based classification scheme for genetically modified foods II: Graded testing. Regulatory Toxicology and Pharmacology 52 (3):223–34. doi:10.1016/j.yrtph.2008.08.002.
  • Chao, E., and D. Krewski. 2008c. A risk-based classification scheme for genetically modified foods III: Evaluation using a panel of reference foods. Regulatory Toxicology and Pharmacology 52 (3):235–41. doi:10.1016/j.yrtph.2008.08.003.
  • Chassy, B., M. Egnin, Y. Gao, K. Glenn, G. Kleter, P. Nestel, M. Newell-McGloughlin, R. Phipps, and R. Shillito. 2007. Nutritional and safety assessments of foods and feeds nutritionally improved through biotechnology: Case studies: Executive summary of a task force report by the international life sciences institute, Washington, D.C. J. Food Sci. 72:R131–R137.
  • Chen, -C.-C., P.-S. Chen, and V.-Y. Yang. 2019. Relationship between fine particulate air pollution exposure and human adult life expectancy in Taiwan. Journal of Toxicology and Environmental Health A 82 (14):826–32. doi:10.1080/15287394.2019.1658386.
  • Cheng, Y. C., M. Musiani, M. Cavedon, and S. Gilch. 2017. High prevalence of prion protein genotype associated with resistance to chronic wasting disease in one Alberta woodland caribou population. Prion 11 (2):136–42. doi:10.1080/19336896.2017.1300741.
  • Christian, M. D., L. Hawryluck, R. S. Wax, T. Cook, N. M. Lazar, M. S. Herridge, M. P. Muller, D. R. Gowans, W. Fortier, and F. M. Burkle. 2006. Development of a triage protocol for critical care during an influenza pandemic. Can Med Assoc J 175 (11):1377–81. doi:10.1503/cmaj.060911.
  • Clean Air Partnership 2009. Climate change adaptation and health equity: Background report. Toronto, ON, Toronto Public Health: Healthy Public Policy Team.
  • Cohen, S. M. 1986. Saccharin: Past, present, and future. Journal of the American Dietetic Association 86 (7):929–31. doi:10.1016/S0002-8223(21)04048-7.
  • Colvin, V. L. 2003. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21 (10):1166–70. doi:10.1038/nbt875.
  • Costa, S., J. Ferreira, C. Silveira, C. Costa, D. Lopes, H. Relvas, C. Borrego, P. Roebeling, A. I. Miranda, and J. P. Teixeira. 2014. Integrating health on air quality assessment—review report on health risks of two major European outdoor air pollutants: PM and NO 2. Journal of Toxicology and Environmental Health B 17 (6):307–40. doi:10.1080/10937404.2014.946164.
  • Cowling, B. J., L. L. H. Lau, P. Wu, H. W. C. Wong, V. J. Fang, S. Riley, and H. Nishiura. 2010. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect. Dis. 10 (1):82–82. doi:10.1186/1471-2334-10-82.
  • Custer, B., and M. P. Janssen. 2015. Health economics and outcomes methods in risk-based decision-making for blood safety. Transfusion 55 (8):2039–47. doi:10.1111/trf.13080.
  • Cutter, S. L., L. Barnes, M. Berry, C. Burton, E. Evans, E. Tate, and J. Webb. 2008. A place-based model for understanding community resilience to natural disasters. Global Environmental Change 18 (4):598–606. doi:10.1016/j.gloenvcha.2008.07.013.
  • Deng, P., X. Zhou, P. Zhou, Z. Du, H. Hou, D. Yang, J. Tan, X. Wu, J. Zhang, Y. Yang, et al. 2008. Edible safety requirements and assessment standards for agricultural genetically modified organisms. Food and Chemical Toxicology 46 (5):1414–36. doi:10.1016/j.fct.2008.01.007.
  • Dusseault, M., and R. Jackson. 2014. Seepage pathway assessment for natural gas to shallow groundwater during well stimulation, in production, and after abandonment. Environmental Geosciences 21 (3):107–26. doi:10.1306/eg.04231414004.
  • EFSA: European Food Safety Authority. 2013. Review of the strategies for the comprehensive food and feed safety and nutritional assessment of GM plants per se. EFSA Supporting Publications 480: 1–115.
  • EFSA Scientific Committee, S. More, V. Bampidis, D. Benford, C. Bragard, T. Halldorsson, A. Hernández-Jerez, S. Hougaard Bennekou, K. Koutsoumanis, and C. Lambré, et al. 2021a. Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: Human and animal health. European Food Safety Authority Journal 19 (8):e06768–e06768. doi:10.2903/j.efsa.2021.6768.
  • EFSA Scientific Committee, More, S., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T., Hernández-Jerez, A., Bennekou, S. H., Koutsoumanis, K., Lambré, C., Machera, K., Naegeli, H., Nielsen, S., Schlatter, J., Schrenk, D., Silano Deceased, V., Turck, D., Younes, M., Castenmiller, J., Chaudhry, Q., … Schoonjans, R. 2021b. Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles. EFSA journal. European Food Safety Authority, 19 (8): e06769.https://doi.org/10.2903/j.efsa.2021.6769.
  • Egbuna, C., V. K. Parmar, J. Jeevanandam, S. M. Ezzat, K. C. Patrick-Iwuanyanwu, C. O. Adetunji, J. Khan, E. N. Onyeike, C. Z. Uche, M. Akram, et al. 2021. Toxicity of nanoparticles in biomedical application: Nanotoxicology. J Toxicol 2021:9954443–9954443. doi:10.1155/2021/9954443.
  • EIA: Energy Information Administration. 2019. Annual energy outlook, energy information administration. United States: Department of Energy.
  • Elsaesser, A., and C. V. Howard. 2012. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 64 (2):129–37. doi:10.1016/j.addr.2011.09.001.
  • EPA: Environmental Protection Agency. 1976. Toxic Substances Control Act. Washington, DC: Environmental Protection Agency.
  • EPA: Environmental Protection Agency. 2005. External review draft nanotechnology white paper. Washington, DC: Science Policy Council, Environmental Protection Agency.
  • EPA: Environmental Protection Agency. 2011. The benefits and costs of the clean air act from 1990 to 2020. U. S. Washington, DC: Environmental Protection Agency.
  • EPA: Environmental Protection Agency. 2017. Environmental Justice. Washington, DC: Environmental Protection Agency.
  • Erickson, T. B., J. Brooks, E. J. Nilles, P. N. Pham, and P. Vinck. 2019. Environmental health effects attributed to toxic and infectious agents following hurricanes, cyclones, flash floods and major hydrometeorological events. Journal of Toxicology and Environmental Health B 22 (5–6):157–71. doi:10.1080/10937404.2019.1654422.
  • Ersdal, G., and T. Aven. 2008. Risk informed decision-making and its ethical basis. Reliability Engineering and AMP; System Safety 93 (2):197–205. doi:10.1016/j.ress.2006.12.018.
  • Evans, J., A. van Donkelaar, R. V. Martin, R. Burnett, D. G. Rainham, N. J. Birkett, and D. Krewski. 2013. Estimates of global mortality attributable to particulate air pollution using satellite imagery. Environ. Res. 120:33–42. doi:10.1016/j.envres.2012.08.005.
  • Ewall, M. 2012. Legal tools for environmental equity vs environmental justice. Sustainable Development Law & Policy 13:55–56.
  • Eze, I. A., L. G. Hemkens, H. C. Bucher, B. Hoffmann, C. Schindler, N. Kunzli, T. Schikowski, and N. M. Probst-Hensch. 2015. Association between ambient air pollution and diabetes mellitus in Europe and North America: Systematic review and meta-analysis. Environ. Health Perspect. 123 (5):381–89. doi:10.1289/ehp.1307823.
  • Farrell, P., P. Aggett, B. Milton, S. Ramoju, D. Mattison, N. Birkett, and D. Krewski. 2022. The use of categorical regression in evidence integration. ALTEX. doi:10.14573/altex.2012022.
  • Farrow, S. 2010. Incorporating equity in regulatory and benefit-cost analysis using risk-based preferences. Risk Analysis 31 (6):902–07. doi:10.1111/j.1539-6924.2010.01474.x.
  • FDA: United States Food and Drug Administration. 2014. Significant dates in U.S. Food and drug law history. Maryland, United States: Silver Spring.
  • Fischhoff, B., P. Slovic, and S. Lichtenstein. 1979. Weighing the risks: Risks: Benefits which risks are acceptable? Environment: Science and Policy for Sustainable Development 21:17–38.
  • Fullerton, M. M., J. Benham, A. Graves, S. Fazel, E. J. Doucette, R. J. Oxoby, M. Mourali, J.-C. Boucher, C. Constantinescu, J. Parsons Leigh, et al. 2022. Challenges and recommendations for COVID-19 public health messaging: A Canada-wide qualitative study using virtual focus groups. BMJ Open 12 (4):e054635–e054635. doi:10.1136/bmjopen-2021-054635.
  • Goldman, A., B. Eggen, B. Golding, and V. Murray. 2014. The health impacts of windstorms: A systematic literature review. Public Health 128 (1):3–28. doi:10.1016/j.puhe.2013.09.022.
  • Goñi, F., C. K. Mathiason, L. Yim, K. Wong, J. Hayes-Klug, A. Nalls, D. Peyser, V. Estevez, N. Denkers, J. Xu, et al. 2015. Mucosal immunization with an attenuated salmonella vaccine partially protects white-tailed deer from chronic wasting disease. Vaccine 33 (5):726–33. doi:10.1016/j.vaccine.2014.11.035.
  • Goodwin, P., S. Brown, I. D. Haigh, R. J. Nicholls, and J. M. Matter. 2018a. Adjusting mitigation pathways to stabilize climate at 1.5°C and 2.0°C rise in global temperatures to year 2300. Earth’s Future 6 (3):601–15. doi:10.1002/2017EF000732.
  • Goodwin, P., A. Katavouta, V. M. Roussenov, G. L. Foster, E. J. Rohling, and R. G. Williams. 2018b. Pathways to 1.5 °C and 2 °C warming based on observational and geological constraints. Nat Geosci 11 (2):102–07. doi:10.1038/s41561-017-0054-8.
  • Government of British Columbia 2013. LNG liquefied natural gas, A strategy for B.C.’s newest industry. Ministry of Energy. Victoria, BC, Canada. Available at: https://news.gov.bc.ca/releases/2013MNGD0049-001916 (Accessed July 15, 2022).
  • Government of British Columbia 2007. The BC energy plan: A vision for clean energy leadership. M. a. P. R. Ministry of Energy. Victoria: Government of BC, Canada: 1–44. Available at: https://www2.gov.bc.ca/assets/gov/farming-natural-resources-and-industry/electricity-alternative-energy/bc_energy_plan_2007.pdf (Accessed July 15, 2022).
  • Government of Canada 2003. A framework for the application of precaution in science-based decision making about risk. Available at: https://publications.gc.ca/site/eng/246284/publication.html (Accessed July 15, 2022).
  • Grandjean, P. 2004. Implications of the precautionary principle for primary prevention and research. Annu. Rev. Public Health 25 (1):199–223. doi:10.1146/annurev.publhealth.25.050503.153941.
  • Gross, M., K. Daginnus, G. Deviller, W. de Wolf, S. Dungey, C. Galli, A. Gourmelon, M. Jacobs, P. Matthiessen, C. Micheletti, et al. 2010. Thresholds of toxicological concern for endocrine active substances in the aquatic environment. Integr Environ Assess Manag 6 (1):2–11. doi:10.1897/IEAM_2008-092.1.
  • Gruenbaum, O. 2019. Commonwealth update. The Commonwealth Journal of International Affairs 108:109–15.
  • Habig, J. W., A. Rowland, M. G. Pence, and C. X. Zhong. 2018. Food safety evaluation for R-proteins introduced by biotechnology: A case study of VNT1 in late blight protected potatoes. Regulatory Toxicology and Pharmacology 95:66–74. doi:10.1016/j.yrtph.2018.03.008.
  • Hagiwara, S., G. M. Paoli, P. S. Price, M. R. Gwinn, A. Guiseppi‐Elie, P. J. Farrell, B. J. Hubbell, D. Krewski, and R. S. Thomas. 2022. A value of information framework for assessing the trade‐offs associated with uncertainty, duration, and cost of chemical toxicity testing. Risk Analysis. Online Ahead of Print. doi:10.1111/risa.13931.
  • Hales, S., S. Edwards, and R. Kovats 2003. Impacts on health of climate extremes. In World Health Organization, climate change and human health: Risks and responses. Geneva: World Health Organization. pp.79–102. Available at https://apps.who.int/iris/bitstream/handle/10665/42742/924156248X_eng.pdf (Accessed July 22, 2022)
  • Haley, N. J., and E. A. Hoover. 2015. Chronic wasting disease of cervids: Current knowledge and future perspectives. Annual Review of Animal Biosciences 3 (1):305–25. doi:10.1146/annurev-animal-022114-111001.
  • Hansson, S. O. 2018. How to perform an ethical risk analysis (eRA). Risk Analysis 38 (9):1820–29. doi:10.1111/risa.12978.
  • Harrison, K., and G. Hoberg. 1994. Risk, science and politics: Regulating toxic substances in Canada and the United States. Montreal: McGill-Queen’s University Press.
  • Hartling, L., W. Pickett, and R. J. Brison. 1999. The injury experience observed in two emergency departments in Kingston, Ontario during ice storm 98. Canadian Journal of Public Health 90 (2):95–98. doi:10.1007/BF03404109.
  • Hay, J., and N. Mimura. 2010. The changing nature of extreme weather and climate events: Risks to sustainable development. Geomatics, Natural Hazards and Risk 1 (1):3–18. doi:10.1080/19475701003643433.
  • Health Canada 2005. Climate change: Preparing for the health impact. In Health Policy Research Bulletin. Ottawa, ON, Health Canada. Available at: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/sr-sr/alt_formats/hpb-dgps/pdf/pubs/hpr-rps/bull/2005-climat/2005-climat-revis-eng.pdf (Accessed July 15, 2022).
  • Health Canada 2008. Human health in a changing climate. In A Canadian assessment of vulnerabilities and adaptive capacity. Ottawa, Canada, Health Canada. Available from: https://publications.gc.ca/site/eng/9.691579/publication.html (Accessed July 15, 2022).
  • Herman, R. A., R. D. Ekmay, B. W. Schafer, P. Song, B. J. Fast, S. Papineni, G. Shan, and D. R. Juberg. 2018. Food and feed safety of DAS-444Ø6-6 herbicide-tolerant soybean. Regulatory Toxicology and Pharmacology 94:70–74. doi:10.1016/j.yrtph.2018.01.016.
  • Herms, J., and M. M. Dorostkar. 2016. Dendritic spine pathology in neurodegenerative diseases. Annual Review of Pathology: Mechanisms of Disease 11 (1):221–50. doi:10.1146/annurev-pathol-012615-044216.
  • Hoffmann, S., and T. Hartung. 2006. Toward an evidence-based toxicology. Hum Exp Toxicol 25 (9):497–513. doi:10.1191/0960327106het648oa.
  • Hrudey, S. E., and D. Krewski. 1995. Is there a safe level of exposure to a carcinogen? Environ. Sci. Technol. 29 (8):370A–375A. doi:10.1021/es00008a747.
  • Hsu, C.-H., and T. Stedeford. 2011. Cancer Risk assessment: Chemical carcinogenesis, hazard evaluation, and risk quantification. 1st ed. Online Library: Wiley.
  • Hunter, P. R., and F. Lorna. 2001. Acceptable risk. Water quality: Guidelines, standards and health. Risk assessment and management for water-related infectious disease. London, UK: IWA Publishing.
  • Hutchison, J. E. 2008. Greener nanoscience: A proactive approach to advancing applications and reducing implications of nanotechnology. ACS Nano 2 (3):395–402. doi:10.1021/nn800131j.
  • IAP2: International Association for Public Participation 2021. Canada inspiring better decisions together. Available from https://www.iap2canada.ca (Accessed July 15, 2022).
  • IARC: International Agency for Research on Cancer. 1999. IARC working group: Saccharin and its salts. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances: IARC monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer. 517–624.
  • IEA: International Energy Agency 2018. Unconventional gas production database. Available at: https://www.iea.org/ugforum/ugd/ (Accessed July 15, 2022).
  • Institute of Medicine. 1999. Toward Environmental Justice: Research, Education, and Health Policy Needs. Washington, DC: National Academies Press.
  • Institute of Medicine. 2005. Implications of Nanotechnology for Environmental Health Research. Washington, DC: National Academies Press.
  • IPCC: Intergovernmental Panel on Climate Change. 2013. Climate change 2013: The physical science basis. Contribution of working group I to the fifth assessment report of the intergovernmental panel on climate change, T. F. Stocker, D. Qin, and G. Plattnered. Geneva, Switzerland: Intergovernmental Panel on Climate Change (IPCC).
  • IPCC: Intergovernmental Panel on Climate Change. 2014a. Climate change 2014: Synthesis report. Contribution of working groups i, ii and iii to the fifth assessment report of the IPCC. Geneva, Switzerland: Intergovernmental Panel on Climate Change (IPCC).
  • IPCC: Intergovernmental Panel on Climate Change 2014b. Frequently asked questions. contribution of working group I contribution to the fifth assessment report of the intergovernmental panel on climate change. IPCC working group I technical support unit. Geneva, Switzerland: Intergovernmental Panel on Climate Change (IPCC).
  • IPCC: Intergovernmental Panel on Climate Change. 2022. Assessment report #6, climate change 2022: Impacts, adaptation and vulnerability, summary for policymakers. Working group ii contribution to the sixth assessment report of the intergovernmental panel on climate change. Geneva, Switzerland: Intergovernmental Panel on Climate Change (IPCC).
  • IRGC: International Risk Governance Council 2007. Nanotechnology risk governance recommendations for a global, coordinated approach to the governance of potential risks. Geneva, Switzerland. Available from https://irgc.org/wp-content/uploads/2018/09/PB_nanoFINAL2_2_.pdf (Accessed July 15, 2022).
  • IRGC: International Risk Governance Council 2014. Risk governance guidelines for unconventional gas development. Lausanne, Switzerland. Available from https://irgc.org/wp-content/uploads/2018/09/IRGC-UGD-Policy-Brief-2014.pdf (Accessed July 15, 2022).
  • IRGC: International Risk Governance Council 2017. Introduction of the IRGC risk governance framework: Revised version. Lausanne, Switzerland. Available from https://irgc.org/wp-content/uploads/2018/09/IRGC.-2017.-An-introduction-to-the-IRGC-Risk-Governance-Framework.-Revised-version.pdf (Accessed July 15, 2022).
  • Jagai, J. S., Q. Li, S. Wang, K. P. Messier, T. J. Wade, and E. D. Hilborn. 2015. Extreme precipitation and emergency room visits for gastrointestinal illness in areas with and without combined sewer systems: An analysis of Massachusetts data, 2003-2007. Environ. Health Perspect. 123 (9):873–79. doi:10.1289/ehp.1408971.
  • Jardine, C., S. Hrudey, J. Shortreed, L. Craig, D. Krewski, C. Furgal, and S. McColl. 2003. Risk management frameworks for human health and environmental risks. Journal of Toxicology and Environmental Health, Part B 6 (6):569–718. doi:10.1080/10937400390208608.
  • Jensen, R. C., and H. Hansen. 2020. Selecting appropriate words for naming the rows and columns of risk assessment matrices. International Journal of Environmental Research and Public Health 17 (15):5521. doi:10.3390/ijerph17155521.
  • Johnson-Arbor, K. K., A. S. Quental, and D. Li. 2014. A comparison of carbon monoxide exposures after snowstorms and power outages. Am J Prev Med 46 (5):481–86. doi:10.1016/j.amepre.2014.01.006.
  • Jonkman, S. N., B. Maaskant, E. Boyd, and M. L. Levitan. 2009. Loss of life caused by the flooding of New Orleans after hurricane Katrina: Analysis of the relationship between flood characteristics and mortality. Risk Analysis 29 (5):676–98. doi:10.1111/j.1539-6924.2008.01190.x.
  • Kamali, M., Z. Khodaparast, and T. Seifi. 2013. Toxicity of engineered nanoparticles – A review. Portugal: University of Beira Interior – Covilhã. https://www.researchgate.net/profile/Tahereh-Seifi/publication/263543579_Toxicity_of_engineered_nanoparticles_-_A_review/links/570ac4f308ae2eb9421fe10e/Toxicity-of-engineered-nanoparticles-A-review.pdf.
  • Keith, D. W., D. K. Weisenstein, J. A. Dykema, and F. N. Keutsch. 2016. Stratospheric solar geoengineering without ozone loss. Proceedings of the National Academy of Sciences of the United States of America 113 (52):14910–14. doi:10.1073/pnas.1615572113.
  • Keller, L. R., and R. K. Sarin. 1988. Equity in social risk: Some empirical observations. Risk Analysis 8 (1):135–46. doi:10.1111/j.1539-6924.1988.tb01160.x.
  • Kelman, S. 1981. Cost-benefit analysis: An ethical critique. Regulation 5 (1):33–40.
  • Kermanizadeh, A., I. Gossens, L. MacCalman, H. Johnston, P. H. Danielsen, N. R. Jacobsen, A.-G. Lenz, T. Fernandes, R. P. F. Schins, F. R. Cassee, et al. 2016. A multilaboratory toxicological assessment of a panel of 10 engineered nanomaterials to human health-ENPRA project-The highlights limitations and current and future challenges. Journal of Toxicology and Environmental Health B 19 (1):1–28. doi:10.1080/10937404.2015.1126210.
  • Kermanizadeh, A., L. G. Powell, and V. Stone. 2020. A review of hepatic nanotoxicology-Summation of recent findings and considerations for the next generation of study designs. Journal of Toxicology and Environmental Health B 23 (4):137–76. doi:10.1080/10937404.2020.1751756.
  • Klima, K., and A. Jerolleman. 2014. Bridging the gap: Hazard mitigation in the global context. Journal of Homeland Security and Emergency Management 11:209–16.
  • Koivisto, R., and D. Douglas 2015. Principles and approaches in ethics assessment. Annex 1.h. ethical assessment of research and innovation: A comparative analysis of practices and institutions in the EU and selected other countries. Available from https://satoriproject.eu/media/1.h-Ethics-and-Risk1.pdf (Accessed July 15, 2022).
  • Kok, E. J., and H. A. Kuiper. 2003. Comparative safety assessment for biotech crops. Trends in Biotechnology 21 (10):439–44. doi:10.1016/j.tibtech.2003.08.003.
  • Krewski, D., D. Acosta, M. Andersen, H. Anderson, J. C. Bailar, K. Boekelheide, R. Brent, G. Charney, V. G. Cheung, S. Green, et al. 2010. Toxicity Testing in the 21st Century: A Vision and a strategy. Journal of Toxicology and Environmental Health B 13 (2–4):51–138. doi:10.1080/10937404.2010.483176.
  • Krewski, D., M. E. Andersen, M. G. Tyshenko, K. Krishnan, T. Hartung, K. Boekelheide, J. F. Wambaugh, D. Jones, M. Whelan, R. Thomas, et al. 2019. Toxicity testing in the 21st century: Progress in the past decade and future perspectives. Arch. Toxicol. 94 (1):1–58. doi:10.1007/s00204-019-02613-4.
  • Krewski, D., V. Hogan, M. C. Turner, P. L. Zeman, I. McDowell, N. Edwards, and J. Losos. 2007. An integrated framework for risk management and population health. Human and Ecological Risk Assessment 13 (6):1288–312. doi:10.1080/10807030701655798.
  • Krewski, D., L. Lemyre, M. C. Turner, J. E. C. Lee, C. Dallaire, L. Bouchard, K. Brand, and P. Mercier. 2008. Public perception of population health risks in Canada: Risk perception beliefs. Health, Risk & Society 10 (2):167–79. doi:10.1080/13698570801919830.
  • Krewski, D., P. Saunders-Hastings, R. A. Baan, T. S. Barton-Maclaren, P. Browne, W. A. Chiu, M. Gwinn, T. Hartung, A. Kraft, J. Lam, et al. 2022. Development of an evidence-based risk assessment framework. ALTEX. In press.
  • Krewski, D., M. Westphal, M. E. Andersen, G. M. Paoli, W. A. Chiu, M. Al-Zoughool, M. C. Croteau, L. D. Burgoon, and I. Cote. 2014. A framework for the next generation of risk science. Environ. Health Perspect. 122 (8):796–805. doi:10.1289/ehp.1307260.
  • Kuzma, J. 2019. Procedurally robust risk assessment framework for novel genetically engineered organisms and gene drives. Regulation & Governance 15 (4):1144–65. doi:10.1111/rego.12245.
  • Ladics, G. S., A. Bartholomaeus, P. Bregitzer, N. G. Doerrer, A. Gray, T. Holzhauser, M. Jordan, P. Keese, E. Kok, P. Macdonald, et al. 2015. Genetic basis and detection of unintended effects in genetically modified crop plants. Transgenic Res. 24 (4):587–603. doi:10.1007/s11248-015-9867-7.
  • Larkin, P., R. Gracie, M. Dusseault, and D. Krewski. 2018. Ensuring health and environmental protection in hydraulic fracturing: A focus on British Columbia and Alberta, Canada. Extractive Industries and Society 5 (4):581–95. doi:10.1016/j.exis.2018.07.006.
  • Leiss, W., M. G. Tyshenko, D. Krewski, N. Cashman, L. Lemyre, M. A. Zoughool, and C. Amaratunga. 2010. Managing the risks of bovine spongiform encephalopathy: A Canadian perspective. Int J Risk Assess Manag 14 (5):381–436. doi:10.1504/IJRAM.2010.035935.
  • Leiss, W., M. G. Tyshenko, P. Larkin, and D. Krewski. 2020. Treaty framing and climate science: Challenges in managing the risk of global warming. International Journal of Global Environmental Issues 19 (1/2/3):273–93. doi:10.1504/IJGENVI.2020.114882.
  • Lowrance, W. W., and J. Klerer. 1976. Of acceptable risk: Science and the determination of safety. Journal of Electrochemical Society 123 (11):373C–373C. doi:10.1149/1.2132690.
  • Lucht, J. M. 2015. Public acceptance of plant biotechnology and GM crops. Viruses 7 (8):4254–81. doi:10.3390/v7082819.
  • Macesker, B., J. J. Myers, V. H. Guthrie, D. A. Walker, and S. G. Schoolcraft. 2002. Quick-reference guide to risk-based decision making (RBDM): A step-by-step example of the RBDM process in the field. https://silo.tips/download/quick-reference-guide-to-risk-based-decision-making-rbdm-a-step-by-step-example.
  • Mayo Clinic. 2022. Thalidomide: Research advances in cancer and other conditions. Available from https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/thalidomide/art-20046534#:~:text=In%20the%201950s%20and%201960s,a%20skin%20condition%20and%20cancer. (Accessed July 15, 2022).
  • Metcalf, C. J. E., M. Ferrari, A. L. Graham, and B. T. Grenfell. 2015. Understanding herd immunity. Trends Immunol. 36 (12):753–55. doi:10.1016/j.it.2015.10.004.
  • Mitchell, R., T. Ogunremi, G. Astrakianakis, E. Bryce, R. Gervais, D. Gravel, L. Johnston, S. Leduc, V. Roth, G. Taylor, et al 2012. Impact of the 2009 influenza A (H1N1) pandemic on Canadian health care workers: A survey on vaccination, illness, absenteeism, and personal protective equipment. American Journal of Infection Control 40 (7):611–16. doi:10.1016/j.ajic.2012.01.011.
  • Moore, M. N. 2006. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 32 (8):967–76. doi:10.1016/j.envint.2006.06.014.
  • Morgan, K. M., A. Crawford, and B. B. Kowalcyk. 2021. Risk-based decision-making definition: A scoping review of food, agricultural, environmental, and medical literature. Risk Anal. 2021 Oct 27. doi: 10.1111/risa.13845.
  • Mouneyrac, C., K. Syberg, and H. Selck. 2015. Ecotoxicological risk of nanomaterials. Aquatic Ecotoxicology, Elsevier 417–40.
  • Mumpower, J. 1986. An analysis of the de minimis strategy for risk management. Risk Analysis 6 (4):437–46. doi:10.1111/j.1539-6924.1986.tb00956.x.
  • Murray, R. 2002. “How Aspartame Became Legal–the Timeline.” Available from https://www.quantumbalancing.com/news/aspartameapproved.htm (Accessed July 15, 2022).
  • NASEM: National Academies of Sciences, Engineering and Medicine. 2020. Framework for Equitable Allocation of COVID-19 Vaccine, Washington DC: National Academies Press.
  • National Assembly. 2016. An Act to implement the 2030 Energy Policy and to amend various legislative provisions. Quebec: Quebec Official Publisher.
  • National Energy Board. 2018. Canada’s energy future 2017 supplement: Conventional, tight, and shale oil production. Ottawa, Canada: Government of Canada.
  • NRC: National Research Council. 1982. Diet, nutrition, and cancer. nutrition committee on diet, and cancer. Washington, DC: National Academies Press.
  • NRC: National Research Council. 1983. Risk assessment in the federal government: Managing the process. Washington, DC: National Academies Press.
  • NRC: National Research Council. 1994. Science and judgment in risk assessment. Committee on risk assessment of hazardous air pollutants. Washington, DC: National Academies Press.
  • NRC: National Research Council. 2007. Toxicity Testing in the 21st Century: A vision and a strategy. Washington, DC: National Academies Press.
  • NRC: National Research Council. 2009. Science and decisions: Advancing risk assessment. Washington, DC: National Academies Press.
  • NRC: National Research Council. 2014. A framework to guide selection of chemical alternatives. Washington, DC: National Academies Press.
  • O’Sullivan, T., and M. Bourgoin 2010. Vulnerability in an influenza pandemic: Looking beyond medical risk. Funded by the public health agency of Canada. Available from https://ighhub.org/sites/default/files/Lit%20Review%20-%20Vulnerability%20in%20Pandemic_FINAL.pdf (Accessed July 22, 2022)
  • Oberdörster, G., E. Oberdörster, and J. Oberdörster. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles [published correction appears in environmental health perspectives 2010:118: A380]. Environ. Health Perspect. 113 (7):823–39. doi:10.1289/ehp.7339.
  • OECD/ITF: Organisation for Economic Co-operation and Development/International Transport Forum 2015. Road Safety Annual Report 2015. Paris, France, OECD.
  • Paoli, P., F. Momoli, M. G. Tyshenko, M. E. Meek, and D. Krewski. 2022. Problem formulation for EFSA scientific assessments 19 (7): 7349E doi:10.2903/sp.efsa.2022.EN-7349.
  • Peterson, M. 2002. What Is a de minimis risk? Risk Management 4 (2):47–55. doi:10.1057/palgrave.rm.8240118.
  • PHAC: Public Health Agency of Canada. 2015. Canadian pandemic influenza preparedness: Planning guidance for the health sector. Ottawa, Canada: Public Health Agency of Canada.
  • Price, P. S., B. J. Hubbell, S. Hagiwara, G. M. Paoli, D. Krewski, A. Guiseppi‐Elie, M. R. Gwinn, N. L. Adkins, and R. S. Thomas. 2021. A framework that considers the impacts of time, cost, and uncertainty in the determination of the cost effectiveness of toxicity‐testing methodologies. Risk Analysis 42 (4):707–29. doi:10.1111/risa.13810.
  • Ramanathan, A. 2019. Toxicity of nanoparticles-challenges and opportunities. Applied Microscopy 49 (2). doi:10.1007/s42649-019-0004-6.
  • Rea, A. W., and W. R. Munns Jr. 2017. The value of nature: Economic, intrinsic, or both? Integr Environ Assess Manag 13 (5):953–55. doi:10.1002/ieam.1924.
  • Revelle, R., and H.E. Suess. 1957. Carbon dioxide exchange between atmosphere and ocean and the question of an increase of atmospheric CO2 during the past decades. Tellus 9:18–27.
  • Rhomberg, L. R., J. E. Goodman, L. A. Bailey, R. L. Prueitt, N. B. Beck, C. Bevan, M. Honeycutt, N. E. Kaminski, G. Paoli, L. H. Pottenger, et al. 2013. A survey of frameworks for best practices in weight-of-evidence analyses. Critical Reviews in Toxicology 43 (9):753–84. doi:10.3109/10408444.2013.832727.
  • Roco, M. C. 2004. Nanoscale science and engineering: Unifying and transforming tools. American Institute of Chemical Engineers Journal 50 (5):890–97. doi:10.1002/aic.10087.
  • Roco, M. C. 2006. What is nanotechnology? Center for Responsible Nanotechnology. Available from http://crnano.org/whatis.htm. (Accessed July 22, 2022)
  • Rozell, D. J. 2018. The ethical foundations of risk analysis. Risk Analysis 38 (8):1529–33. doi:10.1111/risa.12971.
  • Sak, K. 2012. Chemotherapy and dietary phytochemical agents. Chemother Res Pract 2012:282570–282570. doi:10.1155/2012/282570.
  • Samet, J. M., W. A. Chiu, V. Cogliano, J. Jinot, D. Kriebel, R. M. Lunn, F. A. Beland, L. Bero, P. Browne, L. Fritschi, et al. 2020. The IARC monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification. J. Natl. Cancer Inst. 112 (1):30–37. doi:10.1093/jnci/djz169.
  • Saunders-Hastings, P. R., and D. Krewski. 2016. Reviewing the history of pandemic influenza: Understanding patterns of emergence and transmission. Pathogens 5 (4):66. doi:10.3390/pathogens5040066.
  • Saunders-Hastings, P., J. Reisman, D. Krewski, and B. J. Cowling. 2016. Assessing the state of knowledge regarding the effectiveness of interventions to contain pandemic influenza transmission: A systematic review and narrative synthesis. PloS One 11 (12):e0168262. doi:10.1371/journal.pone.0168262.
  • Saunders-Hastings, P., L. Samson, and D. Krewski. 2018. Applying principles of risk decision-making to inform pandemic influenza preparedness and response policy. Chap. 3. In Pandemics: Evolutionary engineering of consciousness and health, ed. P. I. Sidorov. New York: Nova Medicine & Health.
  • Schraufnagel, D. E., J. R. Balmes, C. T. Cowl, S. De Matteis, K. M. S-H-Jung, R. Perez-Padilla, M. B. Rice, H. Riojas-Rodriguez, A. Sood, G. D. Thurston, et al. 2019. Air pollution and noncommunicable diseases: A review by the forum of international respiratory societies environmental committee, part 2: Air pollution and organ systems. Chest 155:417–26. doi:10.1016/j.chest.2018.10.041.
  • Senel, S. 2021. Nanotechnology and animal health. Pharmacy Nanotechnology 9 (1):26–35. doi:10.2174/2211738508666200910101504.
  • Service, R. F. 2005. Calls rise for more research on toxicology of nanomaterials. Science 310 (5754):1609. doi:10.1126/science.310.5754.1609.
  • Silva, G. A. 2005. Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. Surgical Neurology 63 (4):301–06. doi:10.1016/j.surneu.2004.06.008.
  • Sparrow, R. 2009. The social impacts of nanotechnology: An ethical and political analysis. J Bioeth Inq 6 (1):13–23. doi:10.1007/s11673-009-9139-4.
  • Talic, S., S. Shah, H. Wild, D. Gasevic, A. Maharaj, Z. Ademi, X. Li, W. Xu, I. Mesa-Eguiagaray, J. Rostron, et al. 2021. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and COVID-19 mortality: Systematic review and meta-analysis. Br Med J 375:e068302. doi:10.1136/bmj-2021-068302.
  • Toronto Public Health 2016. Building evidence to address the health effects of severe weather. Toronto, Canada, Toronto Public Health. Available from https://www.toronto.ca/legdocs/mmis/2016/hl/bgrd/backgroundfile-98552.pdf (Accessed July 15, 2022).
  • Tsai, -S.-S., Y.-W. Chiu, Y.-H. Weng, and C.-Y. Yang. 2022. Association between fine particulate air pollution and the risk of death from lung cancer in Taiwan. Journal of Toxicology and Environmental Health A 85 (10):431–38. doi:10.1080/15287394.2022.2040672.
  • Tsatsakis, A. M., M. A. Nawaz, D. Kouretas, G. Balias, K. Savolainen, V. A. Tutelyan, K. S. Golokhvast, J. D. Lee, S. H. Yang, and G. Chung. 2017. Environmental impacts of genetically modified plants: A review. Environ. Res. 156:818–33. doi:10.1016/j.envres.2017.03.011.
  • Tyshenko, M. G., N. Farhat, R. Lewis, N. Shilnikova, and D. Krewski. 2010. Applying a precautionary risk management strategy for regulation of nanotechnology. International Journal of Nanotechnology 7 (2/3):243. doi:10.1504/IJNT.2010.031313.
  • Tyshenko, M. G., and D. Krewski. 2008. A risk management framework for the regulation of nanomaterials. International Journal of Nanotechnology 5 (1):143–60. doi:10.1504/IJNT.2008.016553.
  • UK Royal Society and the Royal Academy of Engineering. 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties. London, England: UK Royal Society.
  • United Nations (1992). Rio declaration on environment and development.” In Sustainable Urban Development Reader. Conference on Environment and Development, Routledge,Taylor & Francis.
  • U.S. National Science and Technology Council. 2021. National Nanotechnology Initiative Strategic Plan, A Report by the Subcommittee on Nanoscale Science, Engineering, and Technology Committee on Technology. Alexandria, Virginia pp. 44. https://www.nano.gov/sites/default/files/pub_resource/NNI-2021-Strategic-Plan.pdf
  • Valachis, A., and C. Nilsson. 2015. Cardiac risk in the treatment of breast cancer: Assessment and management. Breast cancer. Vol. 7, 21–35.
  • Van Dorsselaer, A., C. Carapito, F. Delalande, C. Schaeffer-Reiss, D. Thierse, H. Diemer, D. S. McNair, D. Krewski, N. R. Cashman, and J.-L. Darlix. 2011. Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach. PloS one 6 (3):e17815. doi:10.1371/journal.pone.0017815.
  • Verweij, M. 2009. Moral principles for allocating scarce medical resources in an influenza pandemic. J Bioeth Inq 6 (2):159–69. doi:10.1007/s11673-009-9161-6.
  • Viscusi, W. K. 2000. Risk Equity. Journal of Legal Studies 29 (S2):843–71. doi:10.1086/468097.
  • Wagner, R., E. Hildt, E. Grabski, Y. Sun, H. Meyer, A. Lommel, B. Keller-Stanislawski, J. Müller-Berghaus, and K. Cichutek. 2021. Accelerated development of COVID-19 vaccines: Technology platforms, benefits, and associated risks. Vaccines 9 (7):747. doi:10.3390/vaccines9070747.
  • Wang, N., P. Xu, Y. Liu, P. Zhao, J. Ruan, Y. Zheng, J. Jin, S. Wang, J. Yao, D. Xiang, et al. 2020. Efficacy and safety of thalidomide for chemotherapy-induced nausea and vomiting. J Cancer 11 (15):4560–70. doi:10.7150/jca.45678.
  • Watson, O. J., G. Barnsley, J. Toor, A. B. Hogan, P. Winskill, and A. C. Ghani. 2022. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet. Infectious Diseases S1473-3099 (1422):00320–26.
  • Webler, T., and S. Tuler. 2021. Four decades of public participation in risk decision making. Risk Anal. 41 (3):503–18. doi:10.1111/risa.13250.
  • Weihrauch, M. R., and V. Diehl. 2004. Artificial sweeteners—do they bear a carcinogenic risk? Annals of Oncology 15 (10):1460–65. doi:10.1093/annonc/mdh256.
  • Weinstein, M. C., and W. B. Stason. 1977. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296 (13):716–21. doi:10.1056/NEJM197703312961304.
  • Wheeler, D., M. MacGregor, F. Atherton, K. Christmas, S. Dalton, M. Dusseault, G. Gagnon, B. Hayes, C. MacIntosh, I. Mauro, et al. 2015. Hydraulic fracturing – Integrating public participation with an independent review of the risks and benefits. Energy Policy 85:299–308. doi:10.1016/j.enpol.2015.06.008.
  • WHO: World Health Organization 2016. Immunization, vaccines and biologicals: addressing vaccine hesitancy, World Health Organization. Available from https://www.who.int/teams/immunization-vaccines-and-biologicals (Accessed July 15, 2022).
  • WHO: World Health Organization 2021. Review of evidence on health aspects of air pollution: REVIHAAP project: Technical report, World Health Organization. Regional Office for Europe. Available from https://apps.who.int/iris/handle/10665/341712 (Accessed July 15, 2022).
  • WHO: World Health Organization 2022. WHO Coronavirus (COVID-19) Dashboard. from https://covid19.who.int/. (Accessed July 15, 2022).
  • Yu, H., S. Cauchemez, C. A. Donnelly, L. Zhou, L. Feng, N. Xiang, J. Zheng, M. Ye, Y. Huai, Q. Liao, et al. 2012. Transmission dynamics, border entry screening, and school holidays during the 2009 influenza A (H1N1) pandemic, China. Emerging Infect. Dis. 18 (5):758–66. doi:10.3201/eid1805.110356.
  • Zambon, M. C. 1999. Epidemiology and pathogenesis of influenza. Journal of Antimicrobial Chemotherapy 44 (Suppl 2):3–9. doi:10.1093/jac/44.suppl_2.3.
  • Zeckhauser, R. J., and W. K. Viscusi. 1996. The risk management dilemma. Annals of the American Academy of Political and Social Science 545 (1):144–55. doi:10.1177/0002716296545001015.
  • Zhang, J., S. Liu, J. Han, Z. Wang, and S. Zhang. 2021. On the developmental toxicity of silver nanoparticles. Mater Des 203:109611. doi:10.1016/j.matdes.2021.109611.
  • Zhou, Y.-M., S.-J. An, E.-J. Tang, C. Xu, Y. Cao, X.-L. Liu, C.-Y. Yao, H. Xiao, Q. Zhang, F. Liu, et al. 2021. Association between short-term air pollution exposure and depression outpatient visits in cold seasons: A time-series analysis in northwestern China. Journal of Toxicology and Environmental Health A 84 (9):389–98. doi:10.1080/15287394.2021.1880507.
  • Zorrilla, C. 2017. The view from Puerto Rico – Hurricane Maria and its aftermath. New England Journal of Medicine 377 (19):1801–03. doi:10.1056/NEJMp1713196.